NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer Meeting Abstract


Authors: George, T. J.; Yothers, G.; Hong, T. S.; Russell, M. M.; You, Y. N.; Parker, W.; Jacobs, S. A.; Pogue-Geile, K. L.; Gollub, M. J.; Hall, W. A.; Rahma, O. E.; Kachnic, L. A.; Vijayvergia, N.; Wolmark, N.
Abstract Title: NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer
Meeting Title: 2018 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 4 Suppl.
Meeting Dates: 2018 Jan 18-20
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000436174100847
DOI: 10.1200/JCO.2018.36.4_suppl.TPS876
PROVIDER: wos
Notes: Meeting Abstract: TPS876 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marc J Gollub
    208 Gollub